Your session is about to expire
← Back to Search
Fractional CO2 Laser
Single group 30 post menopause females. for Vulvovaginal Atrophy
N/A
Waitlist Available
Research Sponsored by SHERRY Thomas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 month
Awards & highlights
Study Summary
To assess the feasibility and efficacy of the CO2 fractional handpiece in the treatment of vulvovaginal atrophy (VVA) in post-menopausal women and its effect on the patient VHIS(vaginal health index core). The primary endpoint is to assess the change in the vaginal dryness by means of a visual analogic scale (10 cm VAS).
Eligible Conditions
- Vulvovaginal Atrophy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Fractional handpiece with CO2 laser: Fractional Ablative laser Treatment of Vulvovaginal Atrophy (VVA).
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single group 30 post menopause females.Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
SHERRY ThomasLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
Perigree MedicalUNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger